RecruitingPhase 4NCT05702944

The Effect and Safety of Omitting Preoperative Alpha-adrenergic Blockade for Normotensive Pheochromocytoma

Studying Hereditary pheochromocytoma-paraganglioma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Seoul National University Hospital
Principal Investigator
Su-Jin Kim, M.D., Ph.D
Seoul National University Hospital
Intervention
Phenoxybenzamine(drug)
Enrollment
24 enrolled
Eligibility
19-70 years · All sexes
Timeline
20232027

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05702944 on ClinicalTrials.gov

Other trials for Hereditary pheochromocytoma-paraganglioma

Additional recruiting or active studies for the same condition.

See all trials for Hereditary pheochromocytoma-paraganglioma

← Back to all trials